Trial Profile
Safety and efficacy of Tenofovir (TDF)-based therapy in naïve and treatment-experienced patients with chronic hepatitis B: A prospective cohort study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jan 2018
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 18 Jan 2018 New trial record